Literature DB >> 11559313

A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings.

R L Oliveri1, M Muglia, N De Stefano, R Mazzei, A Labate, F L Conforti, A Patitucci, A L Gabriele, G Tagarelli, A Magariello, M Zappia, A Gambardella, A Federico, A Quattrone.   

Abstract

BACKGROUND: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary syndrome caused by mutations of the Notch3 gene, usually localized to exons 3 and 4.
OBJECTIVES: To report a novel pathogenetic mutation occurring in exon 6 of the Notch3 gene, a location not previously recognized in patients with CADASIL, and to report the results of magnetic resonance spectroscopy in CADASIL.
METHODS: Mutation analysis of the Notch3 gene was performed in 2 patients belonging to a large kindred manifesting CADASIL, as well as in 7 clinically unaffected members of the family and 200 control chromosomes. Proton magnetic resonance spectroscopy was used to estimate metabolite resonance intensities in the 2 affected subjects.
RESULTS: Sequence analysis of the Notch3 gene showed a new missense mutation CGC-->TGC in codon 332 of exon 6, resulting in the replacement of an arginine residue with a cysteine. This mutation was never observed in the 7 unaffected members of the family and the 200 control chromosomes examined. Proton magnetic resonance spectroscopy showed a diffuse decrease in cerebral N-acetylaspartate, indicating the presence of widespread axonal damage.
CONCLUSIONS: Our findings emphasize the role of direct DNA sequence analysis for the diagnosis of CADASIL. Moreover, the results of proton magnetic resonance spectroscopy suggest that widespread axonal damage may be an early finding of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559313     DOI: 10.1001/archneur.58.9.1418

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Adaptive metabolic changes in CADASIL white matter.

Authors:  Tamar Akhvlediani; Anke Henning; Peter S Sándor; Peter Boesiger; Hans H Jung
Journal:  J Neurol       Date:  2009-08-19       Impact factor: 4.849

2.  First report of a Tunisian CADASIL patient.

Authors:  Michele Ragno; Katia Nardi; Antonio Manca; Manrico Morroni; Luigi Trojano
Journal:  Neurol Sci       Date:  2012-09-06       Impact factor: 3.307

3.  CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients.

Authors:  Silvia Bianchi; Enza Zicari; Alessandra Carluccio; Ilaria Di Donato; Francesca Pescini; Serena Nannucci; Raffaella Valenti; Michele Ragno; Domenico Inzitari; Leonardo Pantoni; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2014-10-26       Impact factor: 4.849

4.  Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3.

Authors:  Chen-Si Li; Tian-Wei Wang; Jie Wang; Shuai-Hong Li; Na Li; Xiao-Shuang Wang; Le Fang
Journal:  Ann Transl Med       Date:  2020-01

5.  Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients.

Authors:  Neven Maksemous; Robert A Smith; Larisa M Haupt; Lyn R Griffiths
Journal:  Hum Genomics       Date:  2016-11-24       Impact factor: 4.639

6.  Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.

Authors:  Devanshi Patel; Jesse Mez; Badri N Vardarajan; Lyndsay Staley; Jaeyoon Chung; Xiaoling Zhang; John J Farrell; Michael J Rynkiewicz; Lisa A Cannon-Albright; Craig C Teerlink; Jeffery Stevens; Christopher Corcoran; Josue D Gonzalez Murcia; Oscar L Lopez; Richard Mayeux; Jonathan L Haines; Margaret A Pericak-Vance; Gerard Schellenberg; John S K Kauwe; Kathryn L Lunetta; Lindsay A Farrer
Journal:  JAMA Netw Open       Date:  2019-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.